CN101491612B - Medicine for treating mammary hyperplasia and early breast cancer - Google Patents

Medicine for treating mammary hyperplasia and early breast cancer Download PDF

Info

Publication number
CN101491612B
CN101491612B CN2009100196726A CN200910019672A CN101491612B CN 101491612 B CN101491612 B CN 101491612B CN 2009100196726 A CN2009100196726 A CN 2009100196726A CN 200910019672 A CN200910019672 A CN 200910019672A CN 101491612 B CN101491612 B CN 101491612B
Authority
CN
China
Prior art keywords
medicine
radix
root
pill
raw materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100196726A
Other languages
Chinese (zh)
Other versions
CN101491612A (en
Inventor
柴艳峰
闫斌
范希田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009100196726A priority Critical patent/CN101491612B/en
Publication of CN101491612A publication Critical patent/CN101491612A/en
Application granted granted Critical
Publication of CN101491612B publication Critical patent/CN101491612B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating hyperplasia of mammary glands and early breast cancer. The medicine takes red sage root, ganoderma lucidum, safflower, peach kernel, asiatic plantain seed, oldenlandia, rhubarb, chrysanthemum, hawthorn, Chinese lobelia, root of pilose asiabell, cassia twig, root of kudzuvine, bupleurum root, rhizoma corydalis and dandelion herb as raw materials; and the raw materials are evenly mixed and crushed by a 200-mesh screen, and the obtained medicine powder is added with 100g of 60-degree Kaoliang spirit and 50g of honey and then prepared into a pill by the conventional method. The medicine is unique in formulation and has remarkable treatment effects.

Description

A kind of cyclomastopathy and early stage medicine of breast carcinoma for the treatment of
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of cyclomastopathy and early stage medicine of breast carcinoma for the treatment of, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
Background technology
Cyclomastopathy is mainly in 40~50 years old men and women patient, and clinical manifestation is that breast has symptoms such as lump, distending pain of the breast, nipple discharge.At present, the method for treatment cyclomastopathy and breast carcinoma mainly contains operative treatment and western medicine.Operative treatment patient wound is big, painful big; The side effect that the long-term excessive use of medicine of western medicine cyclomastopathy and breast carcinoma is brought is obvious to all, directly influences people's physical and mental health, directly brings spirit and burden economically for patient and family.
Summary of the invention
The purpose of this invention is to provide a kind of with the wet sun of QI invigorating, promote blood circulation that to take off admittedly be the treatment cyclomastopathy of the rule of treatment and the medicine of breast carcinoma, to overcome the deficiencies in the prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's traditional medicine cyclomastopathy and breast carcinoma, with reference to modern pharmacological research, the natural Chinese medicinal herb of therefrom filter out the wet sun of QI invigorating, promoting blood circulation and taking off is admittedly pressed the Chinese medical theory prescription, makes the effect of its unobstructed vessel.
Medicine of the present invention is the medicament of being made by following raw materials by weight proportions: Radix Salviae Miltiorrhizae 30g, Ganoderma 30g, Flos Carthami 15g, Semen Persicae 15g, Semen Plantaginis 20g, Herba Hedyotidis Diffusae 30g, Radix Et Rhizoma Rhei 20g, Flos Chrysanthemi 15g, Fructus Crataegi 15g, Herba Lobeliae Chinensis 30g, Radix Codonopsis 20g, Ramulus Cinnamomi 15g, Radix Puerariae 15g, Radix Bupleuri 12g, Rhizoma Corydalis 12g, Herba Taraxaci 10g; With above-mentioned each component mix homogeneously, reuse 200 mesh sieves are pulverized, and add 60 degree jowar wine 100g and Mel 50g then in medicated powder, make pill according to a conventional method.
Pill of the present invention is an oral medicine, and medicine of the present invention is a Chinese medicine preparation, according to the theory of Chinese medical science prescription, selects that medicine is reasonable, dosage form is advanced, benefiting QI for activating blood circulation, treating both the principal and secondary aspects of a disease.Medicine of the present invention is through clinical observation patient for many years, and evident in efficacy, cyclomastopathy and the early stage patient of breast carcinoma that a variety of causes is caused have remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
1, to select natural plant for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment cyclomastopathy and the breast carcinoma of the medicine of respectively distinguishing the flavor of early stage, and no chemicals is nontoxic to human body, has no side effect, and is safe and reliable.
2, the synthetic ball of the present invention's honey, effective ingredient scatters and disappears few, and the curative effect height is cheap, taking convenience, no any discomfort disease.
3, medicine of the present invention is obvious to cyclomastopathy and breast carcinoma early efficacy.
4, clinical drug of the present invention is observed, and can replace the medicine of other treatment cyclomastopathy and breast carcinoma.
For showing the therapeutic effect of medicine of the present invention to cyclomastopathy and breast carcinoma, the present invention is through the clinical observation of 500 routine cyclomastopathy and breast carcinoma early stage patient system, and select medical history, the state of an illness, age and cyclomastopathy and breast carcinoma early stage patient 100 examples suitable to organize as a comparison with traditional therapy, wherein cyclomastopathy and breast carcinoma early stage patient respectively account for 50%, 40~50 years old age, course of disease February~1 year.Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 3 months, check after a year, and lump disappears not have to recur and is produce effects, and sb.'s illness took a favorable turn is evident as effectively, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Instructions of taking: every 20g, 3 times on the one, warm water delivery service.Clinical realization the results are shown in Table 1.
Table 1: take medicine of the present invention and take the observation of curative effect of conventional medicine to cyclomastopathy and breast carcinoma early stage patient
Group Case load Produce effects (routine number) Effectively (routine number) Invalid (routine number) Total effective rate (%)
Test group 500 252 248 0 100
Matched group 100 0 73 27 73.0
T 2.52 5.78 2.45 3.72
P <0.05 <0.05 <0.05 <0.05 <0.05
As can be seen from Table 1, medicine of the present invention is obtained 252 examples that have of significant curative effect to 500 routine cyclomastopathy and breast carcinoma early stage patient, accounts for 50.4%; That takes a turn for the better has 248 examples, accounts for 49.6%; Total effective rate reaches 100%.
The specific embodiment
Take by weighing raw material by following proportioning: Radix Salviae Miltiorrhizae 30g, Ganoderma 30g, Flos Carthami 15g, Semen Persicae 15g, Semen Plantaginis 20g, Herba Hedyotidis Diffusae 30g, Radix Et Rhizoma Rhei 20g, Flos Chrysanthemi 15g, Fructus Crataegi 15g, Herba Lobeliae Chinensis 30g, Radix Codonopsis 20g, Ramulus Cinnamomi 15g, Radix Puerariae 15g, Radix Bupleuri 12g, Rhizoma Corydalis 12g, Herba Taraxaci 10g;
With above-mentioned each component mix homogeneously, reuse 200 mesh sieves are pulverized, and add 60 degree jowar wine 100g and Mel 50g then in medicated powder, make pill according to a conventional method.

Claims (1)

1. treat cyclomastopathy and the early stage pill of breast carcinoma for one kind, it is characterized in that it is the pill of being made by following raw materials by weight proportions: Radix Salviae Miltiorrhizae 30g, Ganoderma 30g, Flos Carthami 15g, Semen Persicae 15g, Semen Plantaginis 20g, Herba Hedyotidis Diffusae 30g, Radix Et Rhizoma Rhei 20g, Flos Chrysanthemi 15g, Fructus Crataegi 15g, Herba Lobeliae Chinensis 30g, Radix Codonopsis 20g, Ramulus Cinnamomi 15g, Radix Puerariae 15g, Radix Bupleuri 12g, Rhizoma Corydalis 12g, Herba Taraxaci 10g; With above-mentioned each component mix homogeneously, reuse 200 mesh sieves are pulverized, and add 60 degree jowar wine 100g and Mel 50g then in medicated powder, make pill according to a conventional method.
CN2009100196726A 2009-03-09 2009-03-09 Medicine for treating mammary hyperplasia and early breast cancer Expired - Fee Related CN101491612B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100196726A CN101491612B (en) 2009-03-09 2009-03-09 Medicine for treating mammary hyperplasia and early breast cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100196726A CN101491612B (en) 2009-03-09 2009-03-09 Medicine for treating mammary hyperplasia and early breast cancer

Publications (2)

Publication Number Publication Date
CN101491612A CN101491612A (en) 2009-07-29
CN101491612B true CN101491612B (en) 2011-09-14

Family

ID=40922512

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100196726A Expired - Fee Related CN101491612B (en) 2009-03-09 2009-03-09 Medicine for treating mammary hyperplasia and early breast cancer

Country Status (1)

Country Link
CN (1) CN101491612B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104857370A (en) * 2015-06-09 2015-08-26 杜小卫 Traditional Chinese medicine composition for treating breast cancer
CN105454579A (en) * 2015-12-11 2016-04-06 靖州苗族侗族自治县科技推广中心 Health tea capable of preventing breast cancer and preparation method of health tea
CN108992550A (en) * 2018-10-10 2018-12-14 广东云瑶生物医药科技有限公司 A kind of preparation method and applications of the Chinese medicinal compound for tumor of breast disease of preventing epidemic

Also Published As

Publication number Publication date
CN101491612A (en) 2009-07-29

Similar Documents

Publication Publication Date Title
CN102188583A (en) Traditional Chinese medicine for treating infertility
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN102727779B (en) Pharmaceutical composition for treating ovarian cysts and preparation method thereof
CN102363022B (en) Chinese medicine for treating postpartum anemic fainting
CN101491612B (en) Medicine for treating mammary hyperplasia and early breast cancer
CN104173565A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN102284053B (en) Foot bathing preparation for treating insomnia
CN101411770B (en) Medicament for treating blood stasis accumulation type multiple sclerosis symptoms
CN103845620A (en) Traditional Chinese medicine for treating raynaud disease
CN103705846A (en) Traditional Chinese medicine preparation for treating ovarian cyst
CN103316228A (en) Scorpio unsting wine
CN103127272A (en) Chinese medicinal preparation for treating breast disease and preparation method thereof
CN102397438A (en) Medicine for treating low renal function
CN102091296A (en) Medicament for treating breast hyperplasia
CN102526613B (en) Medicament for treating allergic cutaneous vasculitis
CN104435545A (en) Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning
CN102512589B (en) Medicine for treating early sudden deafness
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN101411810A (en) Medicament for treating multiple sclerosis symptoms
CN104587256A (en) Traditional Chinese medicine composition for treating prostatitis
CN102908598B (en) Medicine for treating children fungal pneumonia
CN102526610A (en) Traditional Chinese medicine for curing multiple takayasu arteritis
CN102512546B (en) Traditional Chinese medicine used for esophageal cancer patients refusing surgery
CN101417095B (en) Medicine for treating arthrodynia
CN103933329A (en) Traditional Chinese medicine for treating hypotension

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Chai Yanfeng

Inventor after: Yan Bin

Inventor after: Fan Xitian

Inventor before: Fan Xitian

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: FAN XITIAN TO: CHAI YANFENG YAN BIN FAN XITIAN

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110914

Termination date: 20130309